TH Open (Jan 2024)

Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy

  • Reinhold Kreutz,
  • Gilbert Deray,
  • Jürgen Floege,
  • Marianne Gwechenberger,
  • Kai Hahn,
  • Andreas R. Luft,
  • Pontus Persson,
  • Christoph Axthelm,
  • Juerg Hans Beer,
  • Jutta Bergler-Klein,
  • Nicolas Lellouche,
  • Jens Taggeselle,
  • Jan Beyer-Westendorf

DOI
https://doi.org/10.1055/s-0044-1780529
Journal volume & issue
Vol. 08, no. 01
pp. e106 – e113

Abstract

Read online

Background Patients with atrial fibrillation (AF) and chronic kidney disease (CKD) are at high risk for both thromboembolism and bleeding events. The latter induces a potential reason for withholding oral anticoagulation (OAC) despite an indication for prophylaxis of thromboembolic events.

Keywords